AKT1 and T-cell non-Hodgkin lymphoma: Aberrant overexpression of miR-155 and miR-21 has been observed in natural killer/T cell lymphoma with concurrent downregulation of multiple tumour suppressors resulting in activation of AKT signaling [24].